Triumph Capital Management Decreases Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Triumph Capital Management trimmed its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 21.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 11,480 shares of the pharmacy operator’s stock after selling 3,113 shares during the quarter. Triumph Capital Management’s holdings in Walgreens Boots Alliance were worth $300,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. EverSource Wealth Advisors LLC boosted its holdings in shares of Walgreens Boots Alliance by 308.4% during the 3rd quarter. EverSource Wealth Advisors LLC now owns 1,119 shares of the pharmacy operator’s stock valued at $25,000 after buying an additional 845 shares in the last quarter. Highlander Capital Management LLC bought a new stake in shares of Walgreens Boots Alliance during the 4th quarter valued at $26,000. Venturi Wealth Management LLC boosted its holdings in shares of Walgreens Boots Alliance by 1,241.8% during the 4th quarter. Venturi Wealth Management LLC now owns 1,060 shares of the pharmacy operator’s stock valued at $28,000 after buying an additional 981 shares in the last quarter. FinTrust Capital Advisors LLC boosted its holdings in shares of Walgreens Boots Alliance by 2,314.5% during the 3rd quarter. FinTrust Capital Advisors LLC now owns 1,328 shares of the pharmacy operator’s stock valued at $30,000 after buying an additional 1,273 shares in the last quarter. Finally, Rocky Mountain Advisers LLC bought a new stake in shares of Walgreens Boots Alliance during the 4th quarter valued at $30,000. 58.59% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Walgreens Boots Alliance

In other news, CFO Manmohan Mahajan bought 6,000 shares of the firm’s stock in a transaction on Tuesday, April 2nd. The shares were bought at an average price of $19.38 per share, for a total transaction of $116,280.00. Following the purchase, the chief financial officer now owns 166,969 shares in the company, valued at $3,235,859.22. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, CFO Manmohan Mahajan bought 6,000 shares of the firm’s stock in a transaction on Tuesday, April 2nd. The shares were bought at an average price of $19.38 per share, for a total transaction of $116,280.00. Following the purchase, the chief financial officer now owns 166,969 shares in the company, valued at $3,235,859.22. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Inderpal S. Bhandari bought 3,000 shares of the firm’s stock in a transaction on Thursday, April 11th. The shares were purchased at an average price of $18.05 per share, for a total transaction of $54,150.00. Following the purchase, the director now owns 3,000 shares in the company, valued at approximately $54,150. The disclosure for this purchase can be found here. Company insiders own 17.40% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on WBA shares. UBS Group dropped their price target on shares of Walgreens Boots Alliance from $25.00 to $22.00 and set a “neutral” rating on the stock in a research note on Wednesday, April 3rd. Leerink Partnrs reissued a “market perform” rating on shares of Walgreens Boots Alliance in a research report on Monday, February 26th. Deutsche Bank Aktiengesellschaft cut their price objective on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a “hold” rating on the stock in a research report on Wednesday, April 3rd. TD Cowen cut their price objective on shares of Walgreens Boots Alliance from $37.00 to $35.00 and set a “buy” rating on the stock in a research report on Wednesday, April 3rd. Finally, Truist Financial reissued a “hold” rating and set a $25.00 price objective on shares of Walgreens Boots Alliance in a research report on Monday, April 1st. Four analysts have rated the stock with a sell rating, ten have issued a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $24.36.

Walgreens Boots Alliance Price Performance

WBA opened at $17.34 on Thursday. The company’s 50-day simple moving average is $19.75 and its two-hundred day simple moving average is $21.65. Walgreens Boots Alliance, Inc. has a 52-week low of $17.25 and a 52-week high of $34.60. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.32 and a current ratio of 0.66. The stock has a market capitalization of $14.96 billion, a P/E ratio of -2.48, a P/E/G ratio of 1.10 and a beta of 0.80.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share for the quarter, topping the consensus estimate of $0.82 by $0.38. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The firm had revenue of $37.05 billion for the quarter, compared to analysts’ expectations of $35.86 billion. During the same quarter in the prior year, the business earned $1.16 EPS. The business’s quarterly revenue was up 6.3% on a year-over-year basis. As a group, analysts predict that Walgreens Boots Alliance, Inc. will post 3.23 EPS for the current year.

Walgreens Boots Alliance Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 12th. Stockholders of record on Tuesday, May 21st will be paid a $0.25 dividend. This represents a $1.00 annualized dividend and a dividend yield of 5.77%. The ex-dividend date of this dividend is Monday, May 20th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently -14.29%.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.